Pee Safe Secures $32 Million to Propel Global Hygiene Market Expansion
January 15, 2026, 9:36 am
Pee Safe, a prominent hygiene and wellness brand, recently closed a $32 million Series C funding round. Healthcare-focused private equity firm OrbiMed led this significant investment. The capital injection targets ambitious growth. It will fuel expansion across retail, quick commerce, and e-commerce channels. This strategic move aims to solidify Pee Safe's market leadership. It also plans to broaden its global footprint.
The funding round combines primary capital and secondary share sales. This structure allowed early investor Alkemi Growth Capital to offload a majority stake. Alkemi, a venture capital firm, first backed Pee Safe in 2019. It provided crucial early-stage support. Its exit marks a successful maturation for the startup. OrbiMed’s Dr. Sunny Sharma and Sumona Chakraborty will join Pee Safe’s board. Their expertise offers valuable strategic guidance. This board representation underscores OrbiMed's commitment. It also provides a global healthcare perspective.
Pee Safe, an Indian-born enterprise, is a vital player in the femtech sector. It focuses on accessible hygiene solutions. The company began its journey in 2013. Its initial product was a toilet seat sanitizer. This simple innovation addressed a critical, often overlooked, public health need. It formally launched its broader brand and diverse product portfolio in 2017. Founders Vikas Bagaria and Rithish Kumar spearheaded this expansion. Their vision built a comprehensive wellness brand.
The brand's product range is extensive. It includes toilet hygiene, feminine hygiene, intimate care, personal grooming, and general wellness items. This broad appeal caters to a wide consumer base. It spans various personal care needs. Pee Safe’s innovative approach has garnered significant consumer loyalty. This loyalty is a key factor in its investment appeal. It highlights the brand's potential for sustained growth.
The $32 million investment is earmarked for strategic initiatives. A primary focus involves expanding Pee Safe’s physical retail presence. The company currently boasts an omnichannel network. It spans over 50,000 offline retail points. These are across more than 100 cities. The new funds will deepen this penetration. They will reach even more consumers in urban and semi-urban areas. Strengthening brand-led marketing efforts is another critical objective. This will enhance brand visibility. It will also foster deeper consumer engagement.
Further, Pee Safe plans aggressive growth in quick commerce. This sector demands rapid fulfillment and wide product availability. The funding will accelerate its presence on these platforms. It will also bolster its reach across major e-commerce marketplaces. This multi-pronged distribution strategy ensures maximum market penetration. It caters to modern consumer shopping habits. The goal is to meet consumers wherever they prefer to shop.
Pee Safe’s financial performance demonstrates robust growth. For fiscal year 2025, the company reported over a 45% jump in operating revenue. It reached approximately $9.8 million (Rs 82 crore). Simultaneously, it significantly narrowed its loss. Losses decreased from $1.6 million (Rs 13.2 crore) to around $480,000 (Rs 4 crore). This trajectory indicates a strong path toward profitability. Its annualized net revenue run rate exceeds $18 million (Rs 150 crore). These metrics present a compelling case for investor confidence. They showcase effective operational management.
The wellness and hygiene market, particularly in the femtech segment, is experiencing a surge in investor interest. This wave reflects evolving consumer attitudes. There is increasing awareness about personal health. Stigmas surrounding sexual health and hygiene are diminishing. Younger generations, including Gen Z and millennials, are driving this shift. They seek transparent, effective, and accessible products. Pee Safe is strategically positioned to capitalize on these demographic trends. It provides solutions for an historically underserved category.
OrbiMed's involvement underscores a global perspective on healthcare investments. The firm recognized Pee Safe's differentiated brand. It noted the brand's strong consumer loyalty across large categories. This investment aligns with a broader trend. Global investors are increasingly targeting emerging markets. They seek innovative startups addressing fundamental consumer needs. Pee Safe’s international presence further validates this potential. The company operates in 23 countries. Its products reach diverse demographics worldwide.
The infusion of capital allows Pee Safe to scale operations. It can invest in research and development. This will lead to new product innovations. It also enables technology upgrades. Enhanced digital infrastructure supports its e-commerce goals. The ultimate aim is to create a more integrated and seamless consumer experience. This holistic approach ensures sustainable long-term growth.
This funding round is not just a financial transaction. It signifies a milestone for the Indian startup ecosystem. It highlights the growing maturity of its consumer brands. It also demonstrates their capacity to attract significant international investment. Pee Safe’s success story will inspire other entrepreneurs. It encourages them to address critical social and health needs with innovative business models. The company’s journey from a single product to a multi-category wellness giant exemplifies entrepreneurial spirit. Its market impact continues to expand. The future looks bright for this hygiene innovator.
The funding round combines primary capital and secondary share sales. This structure allowed early investor Alkemi Growth Capital to offload a majority stake. Alkemi, a venture capital firm, first backed Pee Safe in 2019. It provided crucial early-stage support. Its exit marks a successful maturation for the startup. OrbiMed’s Dr. Sunny Sharma and Sumona Chakraborty will join Pee Safe’s board. Their expertise offers valuable strategic guidance. This board representation underscores OrbiMed's commitment. It also provides a global healthcare perspective.
Pee Safe, an Indian-born enterprise, is a vital player in the femtech sector. It focuses on accessible hygiene solutions. The company began its journey in 2013. Its initial product was a toilet seat sanitizer. This simple innovation addressed a critical, often overlooked, public health need. It formally launched its broader brand and diverse product portfolio in 2017. Founders Vikas Bagaria and Rithish Kumar spearheaded this expansion. Their vision built a comprehensive wellness brand.
The brand's product range is extensive. It includes toilet hygiene, feminine hygiene, intimate care, personal grooming, and general wellness items. This broad appeal caters to a wide consumer base. It spans various personal care needs. Pee Safe’s innovative approach has garnered significant consumer loyalty. This loyalty is a key factor in its investment appeal. It highlights the brand's potential for sustained growth.
The $32 million investment is earmarked for strategic initiatives. A primary focus involves expanding Pee Safe’s physical retail presence. The company currently boasts an omnichannel network. It spans over 50,000 offline retail points. These are across more than 100 cities. The new funds will deepen this penetration. They will reach even more consumers in urban and semi-urban areas. Strengthening brand-led marketing efforts is another critical objective. This will enhance brand visibility. It will also foster deeper consumer engagement.
Further, Pee Safe plans aggressive growth in quick commerce. This sector demands rapid fulfillment and wide product availability. The funding will accelerate its presence on these platforms. It will also bolster its reach across major e-commerce marketplaces. This multi-pronged distribution strategy ensures maximum market penetration. It caters to modern consumer shopping habits. The goal is to meet consumers wherever they prefer to shop.
Pee Safe’s financial performance demonstrates robust growth. For fiscal year 2025, the company reported over a 45% jump in operating revenue. It reached approximately $9.8 million (Rs 82 crore). Simultaneously, it significantly narrowed its loss. Losses decreased from $1.6 million (Rs 13.2 crore) to around $480,000 (Rs 4 crore). This trajectory indicates a strong path toward profitability. Its annualized net revenue run rate exceeds $18 million (Rs 150 crore). These metrics present a compelling case for investor confidence. They showcase effective operational management.
The wellness and hygiene market, particularly in the femtech segment, is experiencing a surge in investor interest. This wave reflects evolving consumer attitudes. There is increasing awareness about personal health. Stigmas surrounding sexual health and hygiene are diminishing. Younger generations, including Gen Z and millennials, are driving this shift. They seek transparent, effective, and accessible products. Pee Safe is strategically positioned to capitalize on these demographic trends. It provides solutions for an historically underserved category.
OrbiMed's involvement underscores a global perspective on healthcare investments. The firm recognized Pee Safe's differentiated brand. It noted the brand's strong consumer loyalty across large categories. This investment aligns with a broader trend. Global investors are increasingly targeting emerging markets. They seek innovative startups addressing fundamental consumer needs. Pee Safe’s international presence further validates this potential. The company operates in 23 countries. Its products reach diverse demographics worldwide.
The infusion of capital allows Pee Safe to scale operations. It can invest in research and development. This will lead to new product innovations. It also enables technology upgrades. Enhanced digital infrastructure supports its e-commerce goals. The ultimate aim is to create a more integrated and seamless consumer experience. This holistic approach ensures sustainable long-term growth.
This funding round is not just a financial transaction. It signifies a milestone for the Indian startup ecosystem. It highlights the growing maturity of its consumer brands. It also demonstrates their capacity to attract significant international investment. Pee Safe’s success story will inspire other entrepreneurs. It encourages them to address critical social and health needs with innovative business models. The company’s journey from a single product to a multi-category wellness giant exemplifies entrepreneurial spirit. Its market impact continues to expand. The future looks bright for this hygiene innovator.